Friends,
In the third of my conversation with Dr. Sharman from iwCLL 2013, he discusses the thorny issues of how to treat someone with a 17p del with today's changing options. We start to look at the controversial area of clonal selection.
Thanks
Brian
Interesting to hear Dr Sharman's comments on the struggle when it comes to whether to treat for patients that feel lousy yet their CLL is not progressing and that this results in a more challenging discussion with the patient. For those of us in this situation, the day can't come fast enough when newer, safer drugs remove the quandary of whether to treat with chemotherapy to help a patient feel better.
I find this particular video very interesting as someome who felt unwell but whose CLL had not progressed but who had to just put up with the symptoms. However after undergoing chemo I still do not have this feeling of wellness that I miss so much from my pre CLL days. Also chemo has felt me with a poor immune system and chemo induced pain. Yes chemo killed the cancer but at what price?
Jangreen, Sorry to hear you fell into this 'challenging' category to use Dr Sharman's terminology. Anyone frustrated with the challenges of remaining in W&W can learn from your costly experience. It can't be easy either, hearing patients that have gained entry to recent trials, saying how much better they quickly feel after starting on their trial.
Neil
How do changes in diet affect CLL treatment? Are supplements safe to use? CLL experts Dr. Michael Keating and Dr. Jeff Sharman respondiwCLL 2013: My Advice to Patients about their Therapy and How to Talk with Your Doctors: Shared Decision MakingPart 2 of ASH Interview with Dr. Sharman, a patient meeting in Seattle and off to iwCLL later tonightASH 2013: Dr. John Pagel Discusses Radio-Immune Therapy (RIT) in Chronic Lymphocytic Leukemia (CLL)
Ublituximab plus ibrutinib versus ibrutinib alone for patients with relapsed or refractory high-risk chronic lymphocytic leukaemia (GENUINE)
